June 2021
Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology
Martin J. Edelman, MD, chair of the Department of Hematology/Oncology and associate director for Translational Research at the Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the the nuances of rescinded indications in small-cell lung cancer.
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
3
Making the Genetic Models Match the Ancestry of Patient Populations
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5
